.FDA declines psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Declines to Approve MDMA Treatment, Looking For More Research Study The The Big Apple TimesFDA Rejects Ecstasy-Based Medicine The Stock market JournalFDA rejects to permit novel MDMA therapy to manage PTSD, with ask for more trial records CNNFDA turns down to begin with experimental to address post-traumatic stress disorder, asking for additional research The Washington Message.